- Home
- FF vs RNAC Comparison
FF vs RNAC Comparison
Compare FF & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FF | RNAC |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.1M | 175.8M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | FF | RNAC |
|---|---|---|
| Price | $3.39 | $7.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $38.80 |
| AVG Volume (30 Days) | ★ 201.4K | 177.2K |
| Earning Date | 03-13-2026 | 03-12-2026 |
| Dividend Yield | ★ 7.14% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $137,409,000.00 | $1,091,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.09 | $5.98 |
| 52 Week High | $5.78 | $20.00 |
Technical Indicators
Market Signals| Indicator | FF | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 55.57 | 52.15 |
| Support Level | $3.26 | $7.18 |
| Resistance Level | $3.47 | $7.63 |
| Average True Range (ATR) | 0.09 | 0.54 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 76.81 | 60.75 |
Price Performance
Historical ComparisonAbout FF FutureFuel Corp.
FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.